5-HT Receptor Agonists for the Treatment of Obesity.
作者信息
Kargbo Robert B
机构信息
Usona Institute, 277 Granada Drive, San Luis Obispo, California 93401-7337, United States.
出版信息
ACS Med Chem Lett. 2018 Aug 1;9(9):864-865. doi: 10.1021/acsmedchemlett.8b00328. eCollection 2018 Sep 13.
Abstract
摘要
相似文献
1
5-HT Receptor Agonists for the Treatment of Obesity.用于治疗肥胖症的5-羟色胺受体激动剂
ACS Med Chem Lett. 2018 Aug 1;9(9):864-865. doi: 10.1021/acsmedchemlett.8b00328. eCollection 2018 Sep 13.
2
A short history of the 5-HT receptor: from the choroid plexus to depression, obesity and addiction treatment.5-羟色胺受体简史：从脉络丛到抑郁症、肥胖症及成瘾治疗
Psychopharmacology (Berl). 2017 May;234(9-10):1395-1418. doi: 10.1007/s00213-017-4545-5. Epub 2017 Mar 7.
3
The potential use of selective 5-HT2C agonists in treating obesity.选择性5-羟色胺2C受体激动剂在治疗肥胖症中的潜在用途。
Expert Opin Investig Drugs. 2006 Mar;15(3):257-66. doi: 10.1517/13543784.15.3.257.
4
Agonists of the serotonin 5-HT2C receptor: preclinical and clinical progression in multiple diseases.血清素5-HT2C受体激动剂：多种疾病的临床前及临床进展
Curr Opin Drug Discov Devel. 2008 Jul;11(4):438-45.
5
Ligand-directed serotonin 5-HT receptor desensitization and sensitization.配体定向的血清素 5-HT 受体脱敏和敏化。
Eur J Pharmacol. 2019 Apr 5;848:131-139. doi: 10.1016/j.ejphar.2019.01.037. Epub 2019 Jan 25.
6
From obesity to substance abuse: therapeutic opportunities for 5-HT2C receptor agonists.从肥胖到药物滥用：5-HT2C 受体激动剂的治疗机会。
Trends Pharmacol Sci. 2013 Oct;34(10):560-70. doi: 10.1016/j.tips.2013.08.001. Epub 2013 Sep 13.
7
Role of impulsivity and reward in the anti-obesity actions of 5-HT receptor agonists.5-HT 受体激动剂在抗肥胖中的冲动和奖励作用。
J Psychopharmacol. 2017 Nov;31(11):1403-1418. doi: 10.1177/0269881117735797. Epub 2017 Oct 26.
8
Reciprocal binding properties of 5-hydroxytryptamine type 2C receptor agonists and inverse agonists.5-羟色胺2C型受体激动剂和反向激动剂的相互结合特性。
Mol Pharmacol. 1994 Nov;46(5):937-42.
9
Differences in agonist-independent and -dependent 5-hydroxytryptamine2C receptor-mediated cell division.非激动剂依赖性和激动剂依赖性5-羟色胺2C受体介导的细胞分裂差异。
Mol Pharmacol. 1996 Mar;49(3):474-80.
10
Lorcaserin and CP-809101 reduce motor impulsivity and reinstatement of food seeking behavior in male rats: Implications for understanding the anti-obesity property of 5-HT2C receptor agonists.氯卡色林和CP-809101可降低雄性大鼠的运动冲动性并恢复觅食行为：对理解5-HT2C受体激动剂的抗肥胖特性的启示。
Psychopharmacology (Berl). 2016 Jul;233(14):2841-56. doi: 10.1007/s00213-016-4329-3. Epub 2016 May 30.
本文引用的文献
1
Adipokines, adiposity, and bone marrow adipocytes: Dangerous accomplices in multiple myeloma.脂肪细胞因子、肥胖和骨髓脂肪细胞：多发性骨髓瘤的危险同谋。
J Cell Physiol. 2018 Dec;233(12):9159-9166. doi: 10.1002/jcp.26884. Epub 2018 Jun 26.
2
Long term effects of neonatal exposure to fluoxetine on energy balance: A systematic review of experimental studies.新生儿暴露于氟西汀对能量平衡的长期影响：实验研究的系统评价。
Eur J Pharmacol. 2018 Aug 15;833:298-306. doi: 10.1016/j.ejphar.2018.06.013. Epub 2018 Jun 8.
3
Serotonin Receptor Binding Characteristics of Geissoschizine Methyl Ether, an Indole Alkaloid in Uncaria Hook.钩藤中吲哚生物碱异钩藤碱甲醚的血清素受体结合特性
Curr Med Chem. 2018;25(9):1036-1045. doi: 10.2174/0929867324666170320114713.
4
A short history of the 5-HT receptor: from the choroid plexus to depression, obesity and addiction treatment.5-羟色胺受体简史：从脉络丛到抑郁症、肥胖症及成瘾治疗
Psychopharmacology (Berl). 2017 May;234(9-10):1395-1418. doi: 10.1007/s00213-017-4545-5. Epub 2017 Mar 7.
Zotero 插件